Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
Authors
Keywords
-
Journal
mSphere
Volume 5, Issue 6, Pages -
Publisher
American Society for Microbiology
Online
2020-12-01
DOI
10.1128/msphere.00901-20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progress in EBV Vaccines
- (2019) Dwain G. van Zyl et al. Frontiers in Oncology
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
- (2019) Jessica Marcandalli et al. CELL
- Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
- (2019) Wei Bu et al. IMMUNITY
- Nasopharyngeal carcinoma
- (2019) Yu-Pei Chen et al. LANCET
- A Novel Formulation Strategy to Deliver Combined DNA and VLP Based HPV Vaccine
- (2019) Mohammad Nasir Uddin et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response
- (2019) Arianna Marini et al. Frontiers in Immunology
- Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan
- (2018) Anna E. Coghill et al. CLINICAL CANCER RESEARCH
- An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus
- (2018) Joost Snijder et al. IMMUNITY
- Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk
- (2018) Anna E Coghill et al. JOURNAL OF INFECTIOUS DISEASES
- Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome
- (2018) Zhiwei Liu et al. JOURNAL OF INFECTIOUS DISEASES
- Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry
- (2018) Hua Zhang et al. Nature Microbiology
- Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus
- (2018) Jia Chen et al. Nature Microbiology
- Size-dependent neutralizing activity of gold nanoparticle-based subunit vaccine against dengue virus
- (2018) Quang Huy Quach et al. Acta Biomaterialia
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
- (2018) Dwain G. van Zyl et al. PLoS Pathogens
- Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities
- (2017) Vijayendra Dasari et al. Expert Review of Vaccines
- The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
- (2017) Joseph Torresi Frontiers in Microbiology
- Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV
- (2016) Wei Bu et al. Clinical and Vaccine Immunology
- High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma
- (2016) A. E. Coghill et al. CLINICAL CANCER RESEARCH
- Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus
- (2016) MOLECULES AND CELLS
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- EBV glycoproteins: where are we now?
- (2015) Lindsey M Hutt-Fletcher Future Virology
- Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
- (2015) Hong-Bo Wang et al. Nature Communications
- Epstein-Barr Virus Antibodies and the Risk of Associated Malignancies: Review of the Literature
- (2014) Anna E. Coghill et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory
- (2014) Alan B. Rickinson et al. TRENDS IN IMMUNOLOGY
- Molecular properties of the Epstein-Barr virus BFRF3 gene
- (2013) Mingsheng Cai et al. VIROLOGICA SINICA
- Two Epstein-Barr Virus-Related Serologic Antibody Tests in Nasopharyngeal Carcinoma Screening: Results From the Initial Phase of a Cluster Randomized Controlled Trial in Southern China
- (2012) Z. Liu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Micro and Nanoparticle-Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective
- (2012) Jardin Leleux et al. Advanced Healthcare Materials
- Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China
- (2011) Yue Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
- (2011) J. I. Cohen et al. Science Translational Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search